ResMed (RMD) reported fiscal Q4 non-GAAP earnings late Thursday of $2.55 per diluted share, up from $2.08 a year ago.
Analysts surveyed by FactSet expected $2.49.
Revenue for the quarter ended June 30 was $1.35 billion, up from $1.22 billion a year earlier.
Analysts surveyed by FactSet expected $1.33 billion.
The company said it will raise its quarterly dividend to $0.60 a share, payable Sept. 18 to investors of record on Aug. 14.